《Bioengineering & Translational Medicine》雜志的最新年發(fā)文量為152篇。
這表明該刊在每年都會精選并發(fā)表一定數(shù)量的高質(zhì)量文章，以保持其在工程：生物醫(yī)學領(lǐng)域的學術(shù)影響力。
該刊聚焦于醫(yī)學-工程：生物醫(yī)學領(lǐng)域的前沿研究，致力于推動該領(lǐng)域新技術(shù)和新知識的傳播與應(yīng)用。同時它積極鼓勵研究人員詳細發(fā)表其高質(zhì)量的實驗研究和理論成果。
該刊的平均審稿周期約為 12 Weeks 。
Bioengineering & Translational Medicine 雜志發(fā)文統(tǒng)計
文章名稱引用次數(shù)
- Nanoparticles in the clinic: An update118
- Gelatin-polysaccharide composite scaffolds for 3D cell culture and tissue engineering: Towards natural therapeutics41
- Applications of decellularized extracellular matrix in bone and cartilage tissue engineering30
- Ionic liquids for addressing unmet needs in healthcare27
- Nanocrystals: A perspective on translational research and clinical studies14
- Rescuing mesenchymal stem cell regenerative properties on hydrogel substrates post serial expansion14
- Scalable synthesis and validation of PAMAM dendrimer-N-acetyl cysteine conjugate for potential translation13
- Visible light crosslinkable human hair keratin hydrogels13
- A microfluidic model of human brain (mu HuB) for assessment of blood brain barrier13
- Hepatitis B vaccination using a dissolvable microneedle patch is immunogenic in mice and rhesus macaques11
國家/地區(qū)發(fā)文量
- USA93
- CHINA MAINLAND14
- Singapore6
- South Korea4
- Taiwan4
- Canada3
- India3
- Brazil2
- GERMANY (FED REP GER)2
- Spain2
